Cameron D Thomas

9PUBLICATIONS
51CO-AUTHORS
Cardiology (incl. cardiovascular diseases)Medical biotechnology diagnostics (incl. biosensors)PharmacogenomicsToxicology (incl. clinical toxicology)Gene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Aug 28, 2025
Impact of Race on Profiles of Platelet Reactivity and Clinical Outcomes in Clopidogrel-Treated Participants.

Luis Ortega-Paz, Cameron D Thomas, Claudio Laudani

|Jul 04, 2025
<i>CYP2C19</i> Phenotype, P2Y<sub>12</sub> Inhibitor Selection, and Clinical Outcomes in Patients on Maintenance Clopidogrel Therapy.

Rajiv C Patel, Cameron D Thomas, Joseph S Rossi

|Aug 16, 2024
Precision Antiplatelet Therapy after Percutaneous Coronary Intervention (Precision PCI) Registry - Informing optimal antiplatelet strategies.

Larisa H Cavallari, Craig R Lee, Francesco Franchi

|Jul 20, 2024
Evaluating the Effect of Estimating Renal Function With the CKD-EPI 2021 Equation on the ABCD-GENE Score for Clopidogrel Response Prediction.

Maryam Jamal AlSaeed, Cameron D Thomas, Francesco Franchi

|Jul 02, 2024
Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC) for CYP2D6, ADRB1, ADRB2, ADRA2C, GRK4, and GRK5 Genotypes and Beta-Blocker Therapy.

Julio D Duarte, Cameron D Thomas, Craig R Lee

|Jan 02, 2023
Pharmacogenetics of P2Y<sub>12</sub> receptor inhibitors.

Cameron D Thomas, Alexis K Williams, Craig R Lee

Pageof 2

Frequent Collaborators

7 joint publications

Larisa H Cavallari

7 joint publications

Craig R Lee

4 joint publications

Dominick J Angiolillo

4 joint publications

Francesco Franchi